BACKGROUND: Brain imaging studies of early Alzheimer's disease (AD) have shown decreased metabolism predominantly in the posterior cingulate cortex (PCC), medial temporal lobe, and inferior parietal lobe. This study investigated functional connectivity between these regions, as well as connectivity between these regions and the whole brain. METHODS: Functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI) studies were performed in subjects with early AD, mild cognitive impairment (MCI), and normal controls. RESULTS: The data indicate both decreased fiber connections and disrupted connectivity between the hippocampus and PCC in early AD. The MCI group showed reduced fiber numbers derived from PCC and hippocampus to the whole brain. CONCLUSIONS: The fMRI and DTI results confirmed decreased connectivity from both the PCC and hippocampus to the whole brain in MCI and AD and reduction in connectivity between these two regions, which plausibly represents an early imaging biomarker for AD.
BACKGROUND: Brain imaging studies of early Alzheimer's disease (AD) have shown decreased metabolism predominantly in the posterior cingulate cortex (PCC), medial temporal lobe, and inferior parietal lobe. This study investigated functional connectivity between these regions, as well as connectivity between these regions and the whole brain. METHODS: Functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI) studies were performed in subjects with early AD, mild cognitive impairment (MCI), and normal controls. RESULTS: The data indicate both decreased fiber connections and disrupted connectivity between the hippocampus and PCC in early AD. The MCI group showed reduced fiber numbers derived from PCC and hippocampus to the whole brain. CONCLUSIONS: The fMRI and DTI results confirmed decreased connectivity from both the PCC and hippocampus to the whole brain in MCI and AD and reduction in connectivity between these two regions, which plausibly represents an early imaging biomarker for AD.
Authors: S Duke Han; Konstantinos Arfanakis; Debra A Fleischman; Sue E Leurgans; Elizabeth R Tuminello; Emily C Edmonds; David A Bennett Journal: J Int Neuropsychol Soc Date: 2011-10-18 Impact factor: 2.892
Authors: Paul G Unschuld; Richard A E Edden; Aaron Carass; Xinyang Liu; Megan Shanahan; Xin Wang; Kenichi Oishi; Jason Brandt; Susan S Bassett; Graham W Redgrave; Russell L Margolis; Peter C M van Zijl; Peter B Barker; Christopher A Ross Journal: Mov Disord Date: 2012-05-30 Impact factor: 10.338
Authors: Donna J Cross; Yoshimi Anzai; Eric C Petrie; Nathalie Martin; Todd L Richards; Kenneth R Maravilla; Elaine R Peskind; Satoshi Minoshima Journal: J Nucl Med Date: 2013-06-26 Impact factor: 10.057
Authors: Joseph Therriault; S Wang; S Mathotaarachchi; Tharick A Pascoal; M Parent; T Beaudry; M Shin; Benedet Al; M S Kang; K P Ng; C Dansereau; M T M Park; V Fonov; F Carbonell; E Zimmer; M Mallar Chakravarty; P Bellec; S Gauthier; P Rosa-Neto Journal: Mol Neurobiol Date: 2019-06-22 Impact factor: 5.590
Authors: Alexandra Badea; Lauren Kane; Robert J Anderson; Yi Qi; Mark Foster; Gary P Cofer; Neil Medvitz; Anne F Buckley; Andreas K Badea; William C Wetsel; Carol A Colton Journal: Neuroimage Date: 2016-08-10 Impact factor: 6.556
Authors: J L Woodard; M Seidenberg; K A Nielson; P Antuono; L Guidotti; S Durgerian; Q Zhang; M Lancaster; N Hantke; A Butts; S M Rao Journal: Brain Date: 2009-06-10 Impact factor: 13.501
Authors: J D Bonita; L C C Ambolode; B M Rosenberg; C J Cellucci; T A A Watanabe; P E Rapp; A M Albano Journal: Cogn Neurodyn Date: 2013-09-04 Impact factor: 5.082